Standard Operating Procedure for Validation of Analytical Testing Methods
| Department | Sterile Injectable Manufacturing |
|---|---|
| SOP No. | SOP/SIM/164/2025 |
| Supersedes | SOP/SIM/164/2022 |
| Page No. | Page 1 of 14 |
| Issue Date | 24/06/2025 |
| Effective Date | 26/06/2025 |
| Review Date | 24/06/2026 |
1. Purpose
This SOP defines the procedures and requirements for validating analytical testing methods used to evaluate sterile injectable products. It ensures reliability, consistency, and compliance with international standards such as ICH Q2(R1).
2. Scope
This SOP applies to all analytical methods developed or adapted for the analysis
of sterile injectable products, including raw materials, intermediates, and final product testing. It is applicable to Quality Control (QC) laboratories and R&D departments.
3. Responsibilities
- Analytical Development Team: Develops and drafts validation protocol.
- QC Analyst: Executes validation experiments.
- QA Officer: Reviews protocols, reports, and ensures compliance.
- Head QC: Approves validation outcomes and final reports.
4. Accountability
The Head of Quality Control is accountable for the execution and approval of all method validation activities.
5. Procedure
5.1 Preparation of Validation Protocol
- Define scope, objective, responsibilities, and timelines.
- List materials, equipment, instruments, and acceptance criteria.
- Include ICH validation parameters such as accuracy, precision, specificity, linearity, LOD, LOQ, robustness, and system suitability.
5.2 Execution of Validation
- All experiments must be performed using GMP-compliant practices and documented in real-time.
- Each validation parameter should be tested as described below:
5.2.1 Specificity
- Demonstrate method can distinguish analyte from degradation products, excipients, and matrix.
- Run placebo, blank, and spiked solutions.
5.2.2 Linearity
- Prepare at least 5 concentration levels of standard solutions across the intended range.
- Plot calibration curve and calculate correlation coefficient (r ≥ 0.999).
5.2.3 Accuracy
- Perform recovery studies at 3 different concentrations (e.g., 80%, 100%, 120%).
- Acceptable recovery: 98–102%.
5.2.4 Precision
- Evaluate repeatability (intra-day) and intermediate precision (inter-day or analyst-to-analyst).
- RSD should not exceed 2.0% unless specified otherwise.
5.2.5 Detection and Quantitation Limits (LOD & LOQ)
- Determine using signal-to-noise ratio or standard deviation method.
- LOD: S/N ≥ 3; LOQ: S/N ≥ 10.
5.2.6 Robustness
- Assess effect of small deliberate changes in method parameters (e.g., pH, temperature, mobile phase composition).
- Results should remain within acceptable limits.
5.2.7 System Suitability
- Check resolution, tailing factor, number of theoretical plates, RSD of injections.
- All criteria must comply with method-specific limits.
5.3 Documentation
- Record all raw data in laboratory notebooks or approved data sheets (Annexure-1).
- Compile and analyze results using statistical tools.
- Prepare final validation report and submit for QA review (Annexure-2).
- Maintain records for minimum five years or as per retention policy.
5.4 Revalidation
- Revalidate the method when there are significant changes to:
- Analytical procedure or equipment
- Manufacturing process or formulation
- Analyst or laboratory transfer
5.5 Change Control
- Initiate change control before modifying any validated method.
- Assess impact and decide whether full or partial revalidation is needed.
6. Abbreviations
- SOP: Standard Operating Procedure
- QC: Quality Control
- QA: Quality Assurance
- LOD: Limit of Detection
- LOQ: Limit of Quantitation
- RSD: Relative Standard Deviation
- ICH: International Council for Harmonisation
7. Documents
- Validation Data Sheet – Annexure-1
- Validation Summary Report – Annexure-2
- Change Control Log – Annexure-3
8. References
- ICH Q2(R1) – Validation of Analytical Procedures
- USP General Chapters <1225>, <1226>
- FDA Guidance for Industry on Analytical Procedures and Methods Validation
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | QC Analyst | QA Executive | Head QA |
| Department | Quality Control | Quality Assurance | Quality Assurance |
11. Annexures
Annexure-1: Validation Data Sheet
| Parameter | Tested By | Date | Result | Remarks |
|---|---|---|---|---|
| Linearity | Anil Rathi | 20/06/2025 | r = 0.9998 | Complies |
| Precision | Shweta Mehta | 21/06/2025 | RSD = 1.2% | Complies |
Annexure-2: Validation Summary Report
| Report ID | VAL-2025-16 |
|---|---|
| Method Validated | Assay by HPLC |
| Validated By | QC Department |
| Reviewed By | QA Department |
| Approval Date | 24/06/2025 |
Annexure-3: Change Control Log
| Change ID | Description | Date | Status |
|---|---|---|---|
| CCL-204 | Adjustment of flow rate in assay method | 15/06/2025 | Closed |
Revision History:
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 01/02/2022 | 1.0 | Initial SOP Release | New Method Validation Requirement | QA Head |
| 24/06/2025 | 2.0 | Included revalidation and system suitability | Annual Review | QA Head |